Millions of people could now be cured of sickle cell disease, a serious inherited blood condition, thanks to CRISPR gene editing – but the cost of treatment is so high that few people are likely to receive it in the foreseeable future.
Humanity is “able to cure sickle cell disease using gene editing,” Julie Makani at the Muhimbili University of Health in Tanzania told the International Summit on Human Genome Editing in London on 6 March. …